Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 12.95
-0.25 (-1.89%)
Apr 2, 2026, 4:14 PM AEST
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
1.05M AUD
Profits / Employee
-9.27K AUD
Market Cap
4.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,184 | - | - | 1,120 | 64 |
| Mar 31, 2024 | 431 | 197 | 84.19% | 415 | 16 |
| Dec 31, 2022 | 234 | 76 | 48.10% | 234 | 0 |
| Dec 31, 2021 | 158 | - | - | 158 | 0 |
| Dec 31, 2017 | 9 | - | - | 9 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,904 |
| Clarity Pharmaceuticals | 88 |
| Mesoblast | 81 |
| Starpharma Holdings | 40 |
| Opthea | 33 |
Telix Pharmaceuticals News
- 1 day ago - Telix Appoints David Gill as Non-Executive Director - GlobeNewsWire
- 14 days ago - Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S. - GlobeNewsWire
- 16 days ago - Telix Pharmaceuticals Limited (TLX) Discusses Revenue Growth, Prostate Cancer Imaging Portfolio, and Expansion into Brain and Kidney Cancer Transcript - Seeking Alpha
- 18 days ago - Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA - Nasdaq
- 18 days ago - Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent - Nasdaq
- 18 days ago - Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate - GlobeNewsWire
- 24 days ago - Why Is Telix Pharmaceuticals Stock Gaining Tuesday? - Benzinga
- 24 days ago - Telix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile Transcript - Seeking Alpha